| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 286,555 | 316,181 | 297,031 | 289,458 |
| Cost of sales | 98,443 | 101,625 | 103,145 | 106,441 |
| Gross margin | 188,112 | 214,556 | 193,886 | 183,017 |
| Selling, general and administrative | 116,213 | 151,269 | 121,451 | 119,161 |
| Research and development | 24,241 | 24,579 | 25,016 | 23,869 |
| Total operating expenses | 140,454 | 175,848 | 146,467 | 143,030 |
| Operating income | 47,658 | 38,708 | 47,419 | 39,987 |
| Other income (expense) | 333 | -434 | -4,543 | 184 |
| Earnings before income taxes | 47,991 | 38,274 | 42,876 | 40,171 |
| Income taxes | 9,806 | 15,686 | 7,986 | 6,571 |
| Net earnings | 38,185 | 22,588 | 34,890 | 33,600 |
| Foreign currency translation income (loss) | -2,850 | 5,311 | -25,518 | 21,256 |
| Unrealized gains (losses) on derivative instruments | -1,665 | -1,713 | -45 | -3,027 |
| Other comprehensive income (loss) | -4,515 | 3,598 | -25,563 | 18,229 |
| Comprehensive income | 33,670 | 26,186 | 9,327 | 51,829 |
| Earnings per share, basic | 0.25 | 0.14 | 0.22 | 0.21 |
| Earnings per share, diluted | 0.24 | 0.14 | 0.22 | 0.21 |
| Weighted average number of shares outstanding, basic | 155,464,000 | 157,372,000 | 158,431,000 | 158,531,000 |
| Weighted average number of shares outstanding, diluted | 156,362,000 | 158,944,000 | 160,626,000 | 161,115,000 |
BIO-TECHNE Corp (TECH)
BIO-TECHNE Corp (TECH)